Quote:

---

My interpretation of this is that the prior delay with the Mexico trial was due to the email going to the spam folder and that recently, the problem was identified and the path is moving forward.

---

If this is true, I am unhappy that no one thought to call CytoDyn's Mexican contact to simply check on the progress. Hard to believe that didn't happen.

However, we have lost the strategic value of having that small Mexico trial completed and resulted before the US trials. That would have been important leverage.